Beverly L. Davidson, PhD
Principal Investigator
Dr. Beverly L. Davidson is the Director, Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Chief Scientific Strategy Officer, and holds the Arthur V. Meigs Chair in Pediatrics at Children’s Hospital of Philadelphia. She is Professor of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania.
Training & education:
BS, Nebraska Weslyan University, Lincoln, Neb. (Biology)
PhD, University of Michigan, Ann Arbor, Mich. (Biological Chemistry)
Postdoctoral Fellow, University of Michigan, Ann Arbor, Mich. (Molecular Genetics)
Appointments & Positions:
Professor of Pathology and Laboratory Medicine (2014-present)
Katherine A High Presidential Scholar Endowed Chair in Cell and Gene Therapy (2022-present)
Translational Neuroscience Center Scientific Advisory Board, University of Pennsylvania Perelman School of Medicine (2017-present)
Chief Scientific Strategy Officer, Children's Hospital of Philadelphia (2016-present)
Committee on Appointments and Promotion, University of Pennsylvania Perelman School of Medicine (2016-2022)
Director, Raymond G. Perelman Center for Cellular and Molecular Therapy, Children's Hospital of Philadelphia (2014-present)
Arthur V. Meigs Chair in Pediatrics, Children's Hospital of Philadelphia (2014-2022)
Professional Awards & Honors:
The Leslie Gehry Brenner Prize for Innovation in Science, Hereditary Disease Foundation, 2015
Elected to the American Academy of Arts and Sciences, 2017
F.E. Bennett Memorial Lectureship Award, American Neurological Association, 2018
Election to National Academy of Medicine, 2019
Chair, Gordon Research Conference on Lysosomal Storage Disease, 2019
President of the American Society of Gene and Cell Therapy during 2021–2022
Safadi Lecturer, Safadi Program of Excellence in Clinical and Translational Neuroscience, University of Chicago, 2022
Dr. John W. Schut Research Achievement Award, National Ataxia Foundation, 2023
George Stamatoyannopoulos Memorial Lecture, American Society of Gene and Cell Therapy, 2024
Outstanding Achievement Award, American Society of Gene and Cell Therapy, 2026